Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.

Hemoglobin - 1 Mar 2018

Belhaj Nefissi Rim, Doggui Radhouene, Ouali Faida, Messaoud Taieb, Gritli Nasreddine

Abstract excerpt

Sickle cell disease is a genetic disorder characterized by a hypercoagulable state. Several complications in this hemoglobinopathy are increased by thrombosis. Factor V Leiden (FVL), prothrombin (PRT) G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C mutations are major inherited risk factors of thrombotic complications. In this study, our aim was to compare the frequencies of these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to beta-Thalassemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Hemoglobin, Sickle

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Prothrombin

Share to Thrombophilia

Share to Thrombosis

Source

Identifiers

PMID: 30200836
DOI: 10.1080/03630269.2018.1451340

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.PMID 30200836Read ↗

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.Semantic proximity Read ↗

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.Semantic proximity Read ↗

Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.Semantic proximity Read ↗

Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.Semantic proximity Read ↗

The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.Semantic proximity Read ↗

Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.Semantic proximity Read ↗

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.Semantic proximity Read ↗

Congenital thrombotic risk factors in beta-thalassemia.Semantic proximity Read ↗

Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T.Semantic proximity Read ↗

Analysis of factor V Leiden and prothrombin mutations in patients with suspected thrombophilia in São Paulo state-BrazilSemantic proximity Read ↗

Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.